TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. (Q54508330)

30 May 2018

title

TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. (English)

1 reference

30 May 2018

1 reference

5

Rodolfo Montironi

1 reference

30 May 2018

11

Liang Cheng

1 reference

30 May 2018

Antonio Lopez-Beltran

7

object named as

Antonio Lopez-Beltran

1 reference

30 May 2018

author name string

Andrew B Armstrong

1

1 reference

30 May 2018

Mingsheng Wang

2

1 reference

30 May 2018

John N Eble

3

1 reference

30 May 2018

Gregory T MacLennan

4

1 reference

30 May 2018

Puay-Hoon Tan

6

1 reference

30 May 2018

Shaobo Zhang

8

1 reference

30 May 2018

Lee Ann Baldridge

9

1 reference

30 May 2018

Helena Spartz

10

1 reference

30 May 2018

publication date

7 November 2008

1 reference

30 May 2018

published in

Modern Pathology

1 reference

30 May 2018

volume

22

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

113-118

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.176

exact match

0 references

cites work

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

Carcinosarcoma with rhabdoid features of the urinary bladder in a 2-year-old girl: possible histogenesis of stem cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Malignant mixed mesodermal tumor of bladder occurring after radiotherapy for cervical cancer: report of a case

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Carcinosarcoma (collision tumor) of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Co-Existing Carcinoma and Sarcoma of the Bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Carcinosarcoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Carcinoma and sarcoma of bladder; report of unusual simultaneous occurrence of both tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Osteogenic sarcoma and transitional cell carcinoma occuring simultaneously in the urinary bladder: report of a case

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Carcinosarcoma of urinary bladder: report of 5 cases with immunohistologic study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Urothelial tumorigenesis: a tale of divergent pathways

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.176

7 January 2021

10.1038/MODPATHOL.2008.176

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

18997737

1 reference

30 May 2018